Anaplastic ameloblastic fibrosarcoma arising from recurrent ameloblastic fibroma: restricted molecular abnormalities of certain genes to the malignant transformation

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 104, Issue 1, 2007, Pages 72-75

  Williams, Michelle D ^a   Hanna, Ehab Y ^a   El Naggar, Adel K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ARTICLE; CASE REPORT; FIBROSARCOMA; GENETICS; HUMAN; MALE; MAXILLA TUMOR; MIDDLE AGED; MULTIPLE CANCER; ODONTOGENIC TUMOR; PATHOLOGY; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

FIBROSARCOMA; GENES, P53; HUMANS; MALE; MAXILLARY NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; ODONTOMA; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 34250164181     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2006.07.013     Document Type: Article

References (19)

1. Takeda Y. Ameloblastic fibroma and related lesions: current pathologic concept. Oral Oncol 35 (1999) 535-540
2. Bregni R.C., Taylor A.M., and Garcia A.M. Ameloblastic fibrosarcoma of the mandible: report of two cases and review of the literature. J Oral Pathol Med 30 (2001) 316-320
3. Muller S., Parker D.C., Kapadia S.B., Budnick S.D., and Barnes E.L. Ameloblastic fibrosarcoma of the jaws. A clinicopathologic and DNA analysis of five cases and review of the literature with discussion of its relationship to ameloblastic fibroma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 469-477
4. Leider A.S., Nelson J.F., and Trodahl J.N. Ameloblastic fibrosarcoma of the jaws. Oral Surg Oral Med Oral Pathol 33 (1972) 559-569
5. Park H.R., Shin K.B., Sol M.Y., Suh K.S., and Lee S.K. A highly malignant ameloblastic fibrosarcoma. Report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79 (1995) 478-481
6. Hayashi Y., Tohnai I., Ueda M., and Nagasaka T. Sarcomatous overgrowth in recurrent ameloblastic fibrosarcoma. Oral Oncol 35 (1999) 346-348
7. Beckman R.A., and Loeb L.A. Genetic instability in cancer: theory and experiment. Semin Cancer Biol 15 (2005) 423-435
8. Poetsch M., Zimmermann A., Wolf E., and Kleist B. Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma. Neoplasia 7 (2005) 688-695
9. El-Naggar A.K., Callender D., Coombes M.M., Hurr K., Luna M.A., and Batsakis J.G. Molecular genetic alterations in carcinoma ex-pleomorphic adenoma: a putative progression model?. Genes Chromosomes Cancer 27 (2000) 162-168
10. Takeda Y., Sato H., Satoh M., Nakamura S.I., and Yamamoto H. Immunohistochemical expression of neural tissue markers (neuron-specific enolase, glial fibrillary acidic protein, S100 protein) in ameloblastic fibrodentinoma: a comparative study with ameloblastic fibroma. Pathol Int 50 (2000) 610-615
11. Liu Y., and Rao M.S. Transdifferentiation-fact or artifact. J Cell Biochem 88 (2003) 29-40
12. Katoh M., Shaw C., Xu Q., Van Driessche N., Morio T., Kuwayama H., et al. An orderly retreat: dedifferentiation is a regulated process. Proc Natl Acad Sci U S A 101 (2004) 7005-7010
13. Chen S., Zhang Q., Wu X., Schultz P.G., and Ding S. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 126 (2004) 410-411
14. Batista de Paula A.M., da Costa Neto J.Q., da Silva Gusmao E., Guimaraes Santos F.B., and Gomez R.S. Immunolocalization of the p53 protein in a case of ameloblastic fibrosarcoma. J Oral Maxillofac Surg 61 (2003) 256-258
15. Miettinen M., and Lasota J. KIT (CD117): A Review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol 13 (2005) 205-220
16. Pauser U., da Silva M.T., Placke J., Klimstra D.S., and Kloppel G. Cellular hamartoma resembling gastrointestinal stromal tumor: a solid tumor of the pancreas expressing c-kit (CD117). Mod Pathol 18 (2005) 1211-1216
17. McIntyre A., Summersgill B., Grygalewicz B., Gillis A.J., Stoop J., van Gurp R.J., et al. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults. Cancer Res 65 (2005) 8085-8089
18. Blay J.Y., Le Cesne A., Alberti L., and Ray-Coquart I. Targeted cancer therapies. Bull Cancer 92 (2005) E13-E18
19. Sever M., Jones T.D., Roth L.M., Karim F.W., Zheng W., Michael H., et al. Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications. Mod Pathol 18 (2005) 1411-1416